Clincosm LogoSign in Get a demo

premenopausal breast cancer

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Aug 4, 2023

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

Recruiting
  • Premenopausal Breast Cancer
  • +2 more
  • Taipei City, Taiwan
    Department of Oncology, National Taiwan University Hospital
Feb 7, 2023

Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with

Not yet recruiting
  • Breast Cancer
  • +4 more
  • Ovarian function suppression with endocrine treatments
  • Seoul, Korea, Korea, Republic of
    Gangnam Severance Hospital
Dec 18, 2022

Premenopausal Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Seoul (drug, diagnostic test, procedure)

Recruiting
  • Premenopausal Breast Cancer
  • Hormone Receptor-positive Breast Cancer
  • Tamoxifen Oral Product
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 14, 2022

Ovarian Reserve in Premenopausal Breast Cancer

Terminated
  • Premenopausal Breast Cancer
  • Breast Cancer
    • Dublin, Dublin 18, Ireland
    • +9 more
    Jan 14, 2022

    Premenopausal Breast Cancer Trial in Taipei (Pembrolizumab/ Exemestane/ Leuprolide)

    Recruiting
    • Premenopausal Breast Cancer
    • Pembrolizumab/ Exemestane/ Leuprolide
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 6, 2021

    Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast

    Completed
    Has Results
    • Premenopausal Breast Cancer
    • Leuprorelin acetate
    • Tokyo, Japan
      Takeda selected site
    Oct 9, 2019

    Premenopausal Breast Cancer Trial in Japan (TAP-144-SR(6M), TAP-144-SR(3M))

    Completed
    Has Results
    • Premenopausal Breast Cancer
    • Nagoya-shi, Aichi, Japan
    • +14 more
    Oct 22, 2015